Vanda Pharmaceuticals (VNDA)

6.58 +1.08  +19.64%  May 17, 8:00PM
Add to Watchlists Create an Alert

Vanda Pharmaceuticals Cash and ST Investments:

120.40M for Dec. 31, 2012
View Full Chart

Vanda Pharmaceuticals Cash and ST Investments Chart

    Vanda Pharmaceuticals Historical Cash and ST Investments Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 120.40M
    Sept. 30, 2012 134.40M
    June 30, 2012 144.70M
    March 31, 2012 157.25M
    Dec. 31, 2011 148.88M
    Sept. 30, 2011 161.45M
    June 30, 2011 188.40M
    March 31, 2011 194.56M
    Dec. 31, 2010 198.04M
    Sept. 30, 2010 202.06M
    June 30, 2010 207.12M
    March 31, 2010 202.42M
    Dec. 31, 2009 205.30M
    Sept. 30, 2009 20.68M
    June 30, 2009 29.02M
       
    March 31, 2009 42.64M
    Dec. 31, 2008 46.46M
    Sept. 30, 2008 51.66M
    June 30, 2008 63.07M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro

    About Cash and Short Term Investments

    Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

    Cash and short term investments are considered very liquid assets. For instance, if a company needs immediate liquidity, cash and short term investments can be be quickly used. Cash and short term investments are frequently used in liquidity ratios.
    Learn More

    Get data for

    VNDA Cash and ST Investments Benchmarks

    Companies
    Chelsea Therapeutics International 25.06M
    CEL-SCI Corporation 10.74M
    Peregrine Pharmaceuticals 26.26M

    VNDA Cash and ST Investments Rankings

    Overall 78th percentile
    1650 of 7593
    Sector 74th percentile
    168 of 650 in Healthcare
    Industry 76th percentile
    56 of 237 in Biotechnology

    VNDA Cash and ST Investments Range, Past 5 Years

    Minimum 20.68M Sep 2009
    Maximum 207.12M Jun 2010
    Average 132.55M